Futura Medical plc (FRA:GYX)

Market Cap	3.58M
Revenue (ttm)	9.25M
Net Income (ttm)	-7.34M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	696
Average Volume	13,053
Open	0.0075
Previous Close	0.0075
Day's Range	0.0075 - 0.0075
52-Week Range	0.0075 - 0.3980
Beta	n/a
RSI	43.03
Earnings Date	Dec 12, 2025

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 14
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GYX

Financial Performance

Financial numbers in GBP